Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1441-2022Class II

Nexiva with Single BD Connecta Stopcock Version (20 Ga Blue) Catalog No.383682 (OUS)

Becton Dickinson & Co / initiated 2022-05-09 / Open, Classified

Becton Dickinson & Company began a recall of Nexiva with Single BD Connecta Stopcock Version (20 Ga Blue) Catalog No.383682 (OUS) on . FDA classified it as Class II and gives the reason as "May have the potential for leakage at the housing component of the stopcock, may result in delay or interruption in treatment, exposure to infusate and biohazardous material, under dosing/under infusion, contamination...". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-1441-2022
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Becton Dickinson & Co
Product
Nexiva with Single BD Connecta Stopcock Version (20 Ga Blue) Catalog No.383682 (OUS)
Product code
FMG Stopcock, I.V. Set
Reason for recall
May have the potential for leakage at the housing component of the stopcock, may result in delay or interruption in treatment, exposure to infusate and biohazardous material, under dosing/under infusion, contamination and/or air ingress.
FDA root cause
Under Investigation by firm
Action
BD notified consignees Medical Device Field Correction Notice on 5/9/22 via mail/email. Firm issued Urgent Medical Device Field Correction Letter extended to additional lots on July 13, 2022 via email. Letter states reason for recall, health risk and action to take: Please Take the Following Actions: 1. Inspect your inventory, locate and quarantine any units of the impacted lot numbers and destroy all affected product. 2. For Clinical Users: For devices in situ, check to see if the device is within scope of this Field Safety Notice and replace immediately. If you are unable to determine if the device is within scope, replace the device or continue to monitor for leakage and/or other complications. 3. Share this recall notification with all users within your facility network of the product to ensure they are also aware of this recall. 4. Complete the attached Customer Response Form and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification per FDA requirements and subsequently process your product replacement. North American Regional Complaint Center 1-844-8BD-LIFE (1-844-823-5433) Say Recall when prompted Mon Fri 8:00am and 5:00pm CT for [email protected] General Follow-up, Product Complaints, Technical Questions
Quantity in commerce
44,040
Distribution
Worldwide distribution - US Nationwide distribution in the states of AK, AR, AZ, CA, CO, FL, GA, IL, IN, KS, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NV, NY, OH, OR, PA, SD, TN, TX, UT, VA, WA, WV and the countries of Belgium, China, India, Indonesia, Japan, Korea, Nepal, Philippines, Singapore, Sri Lanka, Thailand, Vietnam.
Product codes and lots
GTIN: 382903836826 Lot Numbers/Exp.Date: 1082423 3/31/2024 1117627 4/30/2024 1140859 5/31/2024 1210968 7/31/2024

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1441-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1431-2022Class IIOngoingVoluntary: Firm initiated
Z-1432-2022Class IIOngoingVoluntary: Firm initiated
Z-1433-2022Class IIOngoingVoluntary: Firm initiated
Z-1434-2022Class IIOngoingVoluntary: Firm initiated
Z-1435-2022Class IIOngoingVoluntary: Firm initiated
Z-1436-2022Class IIOngoingVoluntary: Firm initiated
Z-1437-2022Class IIOngoingVoluntary: Firm initiated
Z-1438-2022Class IIOngoingVoluntary: Firm initiated
Z-1439-2022Class IIOngoingVoluntary: Firm initiated
Z-1440-2022Class IIOngoingVoluntary: Firm initiated
Z-1441-2022Class IIOngoingVoluntary: Firm initiated